NCT05943860已完成不适用
Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 39
- 试验地点
- 2
- 主要终点
- Self-assessment questionnaire for product acceptance by subjects
研究概览
简要总结
The objective of this study is to assess the hair growth efficacy of a Food for Special Medicinal Purposes (FSMP) Pantovigar® vegan after 3 and 6 months of intake.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 75 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Diffuse hair loss
- •Modified Savin Score I to III
- •Hair length of at least 2 cm
排除标准
- •Pathological hair loss (like alopecia areata, universalis or totalis; scarring alopecias; androgenic alopecia; inflammatory conditions of the scalp)
- •Symptomatic diffuse alopecia due to pathological low iron concentration or thyroid gland disorder
- •Acute telogen effluvium
- •Recent or concomitant treatment with any drugs that may cause hair loss
- •Concomitant diseases that can cause hair loss
结局指标
主要结局
Self-assessment questionnaire for product acceptance by subjects
时间窗: Months 6
次要结局
- Change from baseline of several blood parameters: Folic acid(Baseline up to month 6)
- Change from baseline of several blood parameters: Pantothenic Acid(Baseline up to months 6)
- Change from baseline of several blood parameters: Biotin(Baseline up to month 6)
- Effect on hair growth assessed by phototrichogram analysis(Baseline up to month 6)
- Change from baseline of blood parameters: Ferritin(Baseline up to month 6)
- Change from baseline of several blood parameters: Hematocrit(Baseline up to month 6)
- Change from baseline of several blood parameters: Vitamin B1(Baseline up to month 6)
- Occurrence of treatment-emergent adverse reactions and treatment-emergent serious adverse reactions(Baseline up to months 6)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen EffluviumHealthyTelogen EffluviumNCT06545552Activ'inside66
已完成
2 期
A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair LossFemale Pattern Hair LossAndrogenetic Alopecia (AGA)Ludwig Type 1Ludwig Type 2NCT01900041Merz Pharmaceuticals GmbH74
尚未招募
Unknown
Effect of product on hair thickness and hair fallCTRI/2024/08/072061Patanjali Ayurved Limited
尚未招募
Unknown
Checking of safety and efficacy of productCTRI/2024/04/065569KAYA LIMITED
已完成
2 期
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia AreataAlopecia AreataNCT04784533Concert Pharmaceuticals317